CNBC

Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal

29 7 月, 2025

One Min Read

6 Views

The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.

原文: https://www.cnbc.com/2025/07/29/pharma-tariffs-firms-urge-for-clarity-under-eu-us-trade-deal.html

Last Update: 29 7 月, 2025

Written By

Other Articles

Previous

Chiikawa港鐵站襟章贏取攻略　須MTR Mobile登記　8月1日起搭最多合資格車程【附活動詳情】

Next

PayPal于美国推出加密支付支持100多种加密货币并低于信用卡的手续费

Related Posts

Retail investors are running head first into this topsy-turvy market

1 Min Read

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept